Glenn Worman - Jan 29, 2025 Form 4 Insider Report for Drugs Made In America Acquisition Corp. (DMAA)

Role
CFO
Signature
/s/ Glenn Worman
Stock symbol
DMAA
Transactions as of
Jan 29, 2025
Transactions value $
$0
Form type
4
Date filed
2/3/2025, 07:21 PM
Previous filing
Jan 10, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DMAA Ordinary shares Other +100K 100K Jan 29, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 As of the Transaction Date, the reporting person acquired 100,000 ordinary shares from Drugs Made In America Acquisition LLC, the Issuer's sponsor, for no consideration.